Business

FDA halts use of Johnson & Johnson Covid vaccine due to rare blood-clotting issues in six women

Johnson & Johnson COVID-19 vial and box seen at a vaccination site. Doses of the Johnson & Johnson vaccine are being administered throughout the state of Florida despite a small number of patients who have experienced adverse reactions, including blood clots.
Paul Hennessy | LightRocket | Getty Images

The Food and Drug Administration said Tuesday it is asking states to pause using Johnson & Johnson‘s Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots.

This is breaking news. Please check back for updates.

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *